학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 523건 | 목록 1~10
Academic Journal
Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne University, Lausanne, Switzerland.; Loi S; Department of Clinical Medicine and Research, Peter MacCallum Cancer Centre, Melbourne, Australia.; André F; Breast Cancer Unit, Medical Oncology Department, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.; Chandarlapaty S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.; Felip E; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Finn SP; Department of Histopathology and Cancer Molecular Diagnostics, St James's Hospital and Trinity College, Dublin, Ireland.; Jänne PA; Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA.; Kerr KM; Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, UK.; Munzone E; Division of Medical Senology, European Institute of Oncology IRCCS, Milan.; Passaro A; Division of Thoracic Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Pérol M; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Smit EF; Department of Pulmonary Diseases, Leiden University Medical Center, Leiden, The Netherlands.; Swanton C; Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, UK.; Viale G; Department of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Stahel RA; Coordinating Center, ETOP IBCSG Partners Foundation, Bern, Switzerland. Electronic address: rolf.stahel@etop.ibcsg.org.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Editorial & Opinion
Jänne PA; Pasi A. Jänne, MD, PhD, Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA; David Planchard, MD, PhD, Department of Medical Oncology, Thoracic Group and International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France, Faculty of Medicine, Paris-Saclay University, Paris, France; Kunihiko Kobayashi, MD, PhD, Department of Respiratory Medicine, Saitama Medical University, International Medical Center, Hidaka, Japan; and James Chih-Hsin Yang, MD, PhD, Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, National Taiwan University, Taipei, Taiwan.; Planchard D; Pasi A. Jänne, MD, PhD, Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA; David Planchard, MD, PhD, Department of Medical Oncology, Thoracic Group and International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France, Faculty of Medicine, Paris-Saclay University, Paris, France; Kunihiko Kobayashi, MD, PhD, Department of Respiratory Medicine, Saitama Medical University, International Medical Center, Hidaka, Japan; and James Chih-Hsin Yang, MD, PhD, Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, National Taiwan University, Taipei, Taiwan.; Kobayashi K; Pasi A. Jänne, MD, PhD, Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA; David Planchard, MD, PhD, Department of Medical Oncology, Thoracic Group and International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France, Faculty of Medicine, Paris-Saclay University, Paris, France; Kunihiko Kobayashi, MD, PhD, Department of Respiratory Medicine, Saitama Medical University, International Medical Center, Hidaka, Japan; and James Chih-Hsin Yang, MD, PhD, Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, National Taiwan University, Taipei, Taiwan.; Chih-Hsin Yang J; Pasi A. Jänne, MD, PhD, Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA; David Planchard, MD, PhD, Department of Medical Oncology, Thoracic Group and International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France, Faculty of Medicine, Paris-Saclay University, Paris, France; Kunihiko Kobayashi, MD, PhD, Department of Respiratory Medicine, Saitama Medical University, International Medical Center, Hidaka, Japan; and James Chih-Hsin Yang, MD, PhD, Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, National Taiwan University, Taipei, Taiwan.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Yaeger R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Uboha NV; Division of Hematology and Oncology, Department of Medicine, University of Wisconsin, Madison, Wisconsin.; Pelster MS; Sarah Cannon Research Institute, Tennessee Oncology, Nashville, Tennessee.; Bekaii-Saab TS; Department of Medical Oncology and Hematology, Mayo Clinic, Scottsdale, Arizona.; Barve M; Mary Crowley Cancer Research Center, Dallas, Texas.; Saltzman J; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio.; Sabari JK; Division of Medical Oncology, Perlmutter Cancer Center, New York University Langone Health, New York, New York.; Peguero JA; Department of Research, Oncology Consultants PA, Houston, Texas.; Paulson AS; Department of Medical Oncology, Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas.; Jänne PA; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Cruz-Correa M; PanOncology Trials, San Juan, Puerto Rico.; Anderes K; Mirati Therapeutics, a wholly owned subsidiary of Bristol Myers Squibb Company, San Diego, California.; Velastegui K; Mirati Therapeutics, a wholly owned subsidiary of Bristol Myers Squibb Company, San Diego, California.; Yan X; Mirati Therapeutics, a wholly owned subsidiary of Bristol Myers Squibb Company, San Diego, California.; Der-Torossian H; Mirati Therapeutics, a wholly owned subsidiary of Bristol Myers Squibb Company, San Diego, California.; Klempner SJ; Division of Hematology-Oncology, Massachusetts General Cancer Center, Boston, Massachusetts.; Kopetz SE; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
Chang AEB; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA 02114, United States.; Piper-Vallillo AJ; Department of Medicine, Division of Hematology/Oncology, Lahey Hospital and Medical Center, Burlington, MA 01805, United States.; Mak RH; Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA 02215, United States.; Lanuti M; Department of Surgery, Division of Thoracic Surgery, Massachusetts General Hospital, Boston, MA 02114, United States.; Muzikansky A; Massachusetts General Hospital Biostatistics Center, Boston, MA 02114, United States.; Rotow J; Lowe Center for Thoracic Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, United States.; Jänne PA; Lowe Center for Thoracic Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, United States.; Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, United States.; Swanson S; Department of Surgery, Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA 02115, United States.; Wright CD; Department of Surgery, Division of Thoracic Surgery, Massachusetts General Hospital, Boston, MA 02114, United States.; Kozono D; Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA 02215, United States.; Marcoux P; Lowe Center for Thoracic Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, United States.; Piotrowska Z; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA 02114, United States.; Sequist LV; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA 02114, United States.; Willers H; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, United States.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Luo J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Sanchez M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lee E; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hertzler H; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Luong N; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Mazzola E; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Finstein B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Tamen R; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Brisbane G; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Nguyen T; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Paik PK; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Chaft JE; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Cheng ML; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Khalil H; Department of Thoracic Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Piha-Paul SA; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas.; Sholl LM; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Nishino M; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts.; Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.; Hanna GJ; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Center for Head and Neck Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Shapiro GI; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Center for Cancer Therapeutic Innovation, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; French CA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: cfrench@bwh.harvard.edu.
Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
Academic Journal
Odintsov I; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Makarem M; Lowe Center for Thoracic Oncology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Nishino M; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Bachert SE; Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, Kentucky.; Zhang T; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; School of Medicine, New York Medical College, Valhalla, New York.; LoPiccolo J; Lowe Center for Thoracic Oncology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Paweletz CP; Lowe Center for Thoracic Oncology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Gokhale PC; Lowe Center for Thoracic Oncology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ivanova E; Lowe Center for Thoracic Oncology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Saldanha A; Lowe Center for Thoracic Oncology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Rudin CM; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.; Lockwood WW; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Ladanyi M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Somwar R; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Jänne PA; Lowe Center for Thoracic Oncology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Sholl LM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: lmsholl@bwh.harvard.edu.
Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
Academic Journal
Yu HA; Department of Medicine, Medical Oncology, Memorial Sloan Kettering Cancer Center, New York. Electronic address: YuH@mskcc.org.; Baik C; University of Washington/Seattle Cancer Care Alliance, Seattle, USA.; Kim DW; Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea.; Johnson ML; Sarah Cannon Research Institute at Tennessee Oncology, Nashville, USA.; Hayashi H; Kindai University, Osaka.; Nishio M; The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Yang JC; National Taiwan University Hospital, Taipei City.; Su WC; National Cheng Kung University Hospital, Tainan, Taiwan.; Gold KA; Moores Cancer Center at UC San Diego Health, San Diego.; Koczywas M; City of Hope, Duarte, USA.; Smit EF; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Steuer CE; Winship Cancer Institute of Emory University, Atlanta, USA.; Felip E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Murakami H; Shizuoka Cancer Center, Shizuoka, Japan.; Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Su X; Daiichi Sankyo, Inc., Basking Ridge, USA.; Sato S; Daiichi Sankyo Co., Ltd., Tokyo, Japan.; Fan PD; Daiichi Sankyo, Inc., Basking Ridge, USA.; Fujimura M; Daiichi Sankyo Co., Ltd., Tokyo, Japan.; Tanaka Y; Daiichi Sankyo, Inc., Basking Ridge, USA.; Patel P; Daiichi Sankyo, Inc., Basking Ridge, USA.; Sternberg DW; Daiichi Sankyo, Inc., Basking Ridge, USA.; Sellami D; Daiichi Sankyo, Inc., Basking Ridge, USA.; Jänne PA; Dana-Farber Cancer Institute, Boston, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Mok T; Department of Clinical Oncology, State Key Laboratory of Translational Oncology & Chinese University of Hong Kong, Hong Kong, Hong Kong PRC.; Jänne PA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Nishio M; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.; Novello S; Oncology Department at San Luigi Hospital in Orbassano, University of Turin, 10124 Torino, Italy.; Reck M; Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungenClinic, 22927 Grosshansdorf, Germany.; Steuer C; Hematology & Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.; Wu YL; Lung Cancer Institute, Guangdong Province People's Hospital, Guangzhou, 510317, China.; Fougeray R; Oncology Clinical Development, Daiichi Sankyo Inc, Basking Ridge, NJ 07920, USA.; Fan PD; Oncology Clinical Development, Daiichi Sankyo Inc, Basking Ridge, NJ 07920, USA.; Meng J; Oncology Clinical Development, Daiichi Sankyo Inc, Basking Ridge, NJ 07920, USA.; Sternberg DW; Oncology Clinical Development, Daiichi Sankyo Inc, Basking Ridge, NJ 07920, USA.; Esker S; Oncology Clinical Development, Daiichi Sankyo Inc, Basking Ridge, NJ 07920, USA.; Yu HA; Department of Medicine, Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Academic Journal
Pecci F; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States.; Nakazawa S; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Ricciuti B; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States.; Harada G; Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Lee JK; Foundation Medicine, Cambridge, MA, United States.; Alessi JV; Dana-Farber Cancer Institute, Boston, MA, United States.; Barrichello A; Dana-Farber/Harvard Cancer Center, Boston, Massachusetts, United States.; Vaz VR; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Lamberti G; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Di Federico A; University of Bologna, Bologna, Italy.; Gandhi MM; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States.; Gazgalis D; Dana-Farber Cancer Institute, Boston, MA, United States.; Feng WW; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Jiang J; Dana-Farber Cancer Institute, Boston, MA, United States.; Baldacci S; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Locquet MA; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Gottlieb FH; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Chen MF; Memorial Sloan Kettering Cancer Center, New York, New York, United States.; Lee E; Dana-Farber Cancer Institute, Boston, MA, United States.; Haradon D; Dana-Farber Cancer Institute, United States.; Smokovich A; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Voligny E; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Nguyen T; Dana-Farber Cancer Institute, Boston, MA, United States.; Goel VK; Turning Point Therapeutics, San Diego, California, United States.; Zimmerman Z; Turning Point Therapeutics, a wholly owned subsidiary of Bristol Myers Squibb Company, San Diego, CA, United States.; Atwal S; Turning Point Therapeutics, a wholly owned subsidiary of Bristol Myers Squibb Company, San Diego, CA, United States.; Wang X; Harvard T.H. Chan School of Public Health, Boston, MA, United States.; Bahcall M; Dana-Farber Cancer Institute, Boston, MA, United States.; Heist RS; Massachusetts General Hospital, Boston, MA, United States.; Iqbal S; Broad Institute, Cambridge, MA, United States.; Gandhi N; Caris Life Sciences (United States), Phoenix, AZ, United States.; Elliott A; Caris Life Sciences (United States), Phoenix, AZ, United States.; Vanderwalde AM; Caris Life Sciences (United States), Memphis, TN, United States.; Ma PC; Penn State Milton S. Hershey Medical Center, Hershey, PA, United States.; Halmos B; Montefiore Medical Center, Bronx, NY, United States.; Liu SV; Georgetown University, Washington, DC, United States.; Che J; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Schrock AB; Foundation Medicine Inc., Cambridge, MA, United States.; Drilon A; Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Janne PA; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Awad MM; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
Smit EF; Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pulmonary Diseases, Leiden University Medical Center, Leiden, Netherlands. Electronic address: e.f.smit@LUMC.nl.; Felip E; Department of Oncology, Vall d'Hebron University and Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Uprety D; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA.; Nagasaka M; University of California Irvine, School of Medicine, Orange, CA, USA.; Nakagawa K; Department of Medical Oncology, Kindai University, Osaka-Sayama, Japan.; Paz-Ares Rodríguez L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Pacheco JM; Department of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Li BT; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Planchard D; Department of Medical Oncology, Thoracic Cancer Group, Gustave Roussy, Villejuif, France.; Baik C; Department of Medical Oncology, University of Washington, Seattle, WA, USA.; Goto Y; National Cancer Center Hospital, Tokyo, Japan.; Murakami H; Shizuoka Cancer Center, Shizuoka, Japan.; Saltos A; Moffitt Cancer Center, Tampa, FL, USA.; Pereira K; Daiichi Sankyo, Basking Ridge, NJ, USA.; Taguchi A; Daiichi Sankyo, Tokyo, Japan.; Cheng Y; Daiichi Sankyo, Basking Ridge, NJ, USA.; Yan Q; Daiichi Sankyo, Basking Ridge, NJ, USA.; Feng W; Daiichi Sankyo, Basking Ridge, NJ, USA.; Tsuchihashi Z; Daiichi Sankyo, Basking Ridge, NJ, USA.; Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Janne PA
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어